Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ASH news on hypertension.

A Cases1,

  • 1Department of Nephrology, Hospital Clinic, Barcelona, Spain.

Drug News & Perspectives
|August 26, 2003
PubMed
Summary

The 15th American Society of Hypertension meeting highlighted cardiovascular disease research. Key findings from major trials like HOPE and ALLHAT, plus omapatrilat data, were presented.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study.

The journal of headache and pain·2025
Same author

Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.

Drugs of today (Barcelona, Spain : 1998)·2018
Same author

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Journal of thrombosis and haemostasis : JTH·2018
Same author

[Anemia of chronic kidney disease: Protocol of study, management and referral to Nephrology].

Semergen·2017
Same author

Efficacy of a simple dosage scheme to convert from shorter-acting erythropoiesis-stimulating agent to continuous erythropoietin receptor activator in kidney transplantation patients.

Transplantation proceedings·2015
Same author

[Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia·2010

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Clinical Trials

Background:

  • The 15th Scientific Meeting of the American Society of Hypertension convened in May 2000.
  • Focus was on basic science and clinical aspects of cardiovascular disease.
  • Recent large-scale clinical trials were a key discussion point.

Purpose of the Study:

  • To present and discuss new findings in hypertension and cardiovascular disease.
  • To review outcomes from major morbidity and mortality trials.
  • To report the latest clinical data for the drug omapatrilat.

Main Methods:

  • Discussions and presentations of data from completed and ongoing clinical trials.
  • Focus on morbidity and mortality outcomes.
  • Review of specific drug trial results (omapatrilat).

Main Results:

  • New findings from HOPE (Heart Outcomes Prevention Evaluation), SECURE, ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial), and DASH-sodium trials were discussed.
  • Latest clinical findings for omapatrilat were presented.
  • The meeting covered both fundamental research and clinical applications in cardiovascular disease.

Conclusions:

  • The meeting provided a comprehensive overview of recent advancements in hypertension research.
  • Key clinical trials are shaping the understanding of cardiovascular disease management.
  • Omapatrilat data suggests ongoing developments in therapeutic options.

Related Experiment Videos